Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Sihuan Kebao Pharmaceutical is a specialized pharmaceutical company based in China and a key subsidiary of the Sihuan Pharmaceutical Group. The company focuses on the research, development, and manufacturing of high-quality generic and innovative drugs, with a strong emphasis on cardiovascular and central nervous system (CNS) therapeutic areas. Its product portfolio includes a wide range of formulations such as injections, tablets, and capsules, many of which are integrated into China's national medical insurance system. Beijing Sihuan Kebao operates modern manufacturing facilities that comply with national GMP standards, supporting the group's broader mission of providing affordable and effective healthcare solutions. The company plays a vital role in the production of the group's core products, contributing significantly to its market leadership in the Chinese hospital market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Sihuan Kebao Pharmaceutical.